1-5 of 5
Carine Tang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors

Amy Hughes, Jade Clarson, Carine Tang, Ljiljana Vidovic, Deborah L. White, Timothy P. Hughes, Agnes S. M. Yong
Journal: Blood
Blood (2017) 129 (9): 1166–1176.
https://doi.org/10.1182/blood-2016-10-745992
Published: 2017
Includes: Supplemental data
Journal Articles

KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy

Clinical Trials & Observations Brief Report
David T. Yeung, Carine Tang, Ljiljana Vidovic, Deborah L. White, Susan Branford, Timothy P. Hughes, Agnes S. Yong
Journal: Blood
Blood (2015) 126 (25): 2720–2723.
https://doi.org/10.1182/blood-2015-07-655589
Published: 2015
Includes: Supplemental data
Journal Articles

Chronic Myeloid Leukemia Patients with Deep Molecular Responses to Tyrosine Kinase Inhibitors Have Increased Effector Natural Killer and Cytotoxic T Cell Immune Responses to Leukaemia-Associated Antigens and Concomitant Reduced Immune Suppressors

Amy Hughes, B.Sc (hons), PhD, Carine Tang, B.Sc (hons), PhD, Jade Clarson, B.Sc, Ljiljana Vidovic, Animal Sc (hons), Timothy P. Hughes, MD MBBS, FRACP, FRCPA, Agnes S Yong, MD PhD
Journal: Blood
Blood (2015) 126 (23): 18.
https://doi.org/10.1182/blood.V126.23.18.18
Published: 2015
Journal Articles

KIR2DL5B Genotype Independently Predicts Poor Outcomes in CML-CP Patients Switched to Nilotinib after Suboptimal Responses to Imatinib and May Refine Prognosis in Patients with EMR Failure

David T Yeung, BSc, MBBS, FRACP, FRCPA, Ljiljana Vidovic, BSc, Carine Tang, BSc., (Hons) PhD, Deborah L White, PhD FFSc (RCPA), Susan Branford, PhD, Timothy P Hughes, MD MBBS, FRACP, FRCPA, Agnes S.M. Yong, MD PhD
Journal: Blood
Blood (2014) 124 (21): 814.
https://doi.org/10.1182/blood.V124.21.814.814
Published: 2014
Journal Articles

Modelling of TKI Resistance In CML Cell Lines: Kinase Domain Mutations Usually Arise In the Setting of BCR-ABL Overexpression.

Carine Tang, BSc., (Hons), Lisa Schafranek, BSc., (Hons), Dale Watkins, BSc., (Hons), Wendy T Parker, PhD, Jodi Prime, BSc., Deborah L White, PhD, Timothy Hughes, MD, MBBS
Journal: Blood
Blood (2010) 116 (21): 3383.
https://doi.org/10.1182/blood.V116.21.3383.3383
Published: 2010